Chile

6 Vaccines Approved for Use in Chile

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ispch.cl
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: voanews.com

7 in Clinical Trials in Chile

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector

CanSino

Ad5-nCoV-IH

3 trials in 3 countries
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries